Active Ingredient History
Cefadroxil is a new semisynthetic cephalosporin with a broad antibacterial spectrum and a high chemotherapeutic potential when administered orally. Many studies have established the efficacy of the administration of once- or twice-daily cefadroxil in the management of infections in the respiratory tract, urinary tract, skin and soft tissues, and bones and joints. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Bacterial Infections (approved 1978)
Anti-Infective Agents (Phase 4)
Arthritis, Infectious (Phase 1)
Bacterial Infections (Phase 4)
Bone Diseases, Infectious (Phase 4)
Breast Implantation (Phase 4)
Cystitis (Phase 4)
Healthy Volunteers (Phase 1)
Infections (Phase 4)
Intestinal Neoplasms (Phase 4)
Osteomyelitis (Phase 1)
Pyomyositis (Phase 1)
Urinary Tract Infections (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
